Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Other Operating Expenses (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Other Operating Expenses data on record, last reported at $1.4 million in Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 12.09% year-over-year to $1.4 million; the TTM value through Sep 2025 reached $6.8 million, down 90.04%, while the annual FY2024 figure was $66.7 million, 155.65% up from the prior year.
  • Other Operating Expenses reached $1.4 million in Q3 2025 per TNXP's latest filing, down from $3.3 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $62.3 million in Q2 2024 and bottomed at $943000.0 in Q1 2025.
  • Average Other Operating Expenses over 3 years is $8.6 million, with a median of $1.7 million recorded in 2024.
  • The widest YoY moves for Other Operating Expenses: up 12.09% in 2025, down 94.75% in 2025.
  • A 3-year view of Other Operating Expenses shows it stood at $2.4 million in 2023, then tumbled by 50.02% to $1.2 million in 2024, then rose by 15.55% to $1.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $1.4 million in Q3 2025, $3.3 million in Q2 2025, and $943000.0 in Q1 2025.